JP2023538002A5 - - Google Patents
Info
- Publication number
- JP2023538002A5 JP2023538002A5 JP2023509853A JP2023509853A JP2023538002A5 JP 2023538002 A5 JP2023538002 A5 JP 2023538002A5 JP 2023509853 A JP2023509853 A JP 2023509853A JP 2023509853 A JP2023509853 A JP 2023509853A JP 2023538002 A5 JP2023538002 A5 JP 2023538002A5
- Authority
- JP
- Japan
- Prior art keywords
- regulatory
- cells
- polypeptide
- polypeptides
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063065029P | 2020-08-13 | 2020-08-13 | |
| US63/065,029 | 2020-08-13 | ||
| PCT/US2021/045908 WO2022036193A2 (en) | 2020-08-13 | 2021-08-13 | Regulatory t cell epitopes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538002A JP2023538002A (ja) | 2023-09-06 |
| JP2023538002A5 true JP2023538002A5 (https=) | 2024-04-01 |
Family
ID=80246635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509853A Pending JP2023538002A (ja) | 2020-08-13 | 2021-08-13 | 制御性ｔ細胞エピトープ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230321237A1 (https=) |
| EP (1) | EP4196232A2 (https=) |
| JP (1) | JP2023538002A (https=) |
| CA (1) | CA3188962A1 (https=) |
| WO (1) | WO2022036193A2 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2371913T3 (es) * | 2003-01-22 | 2012-01-11 | Duke University | Constructos mejorados para expresar polipéptidos lisosomales. |
| EP2450368A1 (en) * | 2007-01-30 | 2012-05-09 | Epivax, Inc. | Regulatory t cell epitopes, compositions and uses thereof |
-
2021
- 2021-08-13 US US18/040,226 patent/US20230321237A1/en active Pending
- 2021-08-13 EP EP21856771.7A patent/EP4196232A2/en not_active Withdrawn
- 2021-08-13 WO PCT/US2021/045908 patent/WO2022036193A2/en not_active Ceased
- 2021-08-13 CA CA3188962A patent/CA3188962A1/en active Pending
- 2021-08-13 JP JP2023509853A patent/JP2023538002A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515386A (ja) | 制御性ｔ細胞エピトープと脱寛容化ｓａｒｓ－ｃｏｖ－２抗原 | |
| JP2022177270A (ja) | 調節性ｔ細胞エピトープ、組成物およびその使用 | |
| US20200407406A1 (en) | Peptides and methods for the treatment of diabetes | |
| AU2018346681B2 (en) | Regulatory T cell epitopes | |
| US11911414B2 (en) | Regulatory T cell epitopes | |
| JP2023538002A5 (https=) | ||
| US20230279072A1 (en) | Regulatory t cell epitopes | |
| US20230321237A1 (en) | Regulatory t cell epitopes | |
| US20240173377A1 (en) | Retro - inverso regulatory t cell epitopes | |
| US20230158165A1 (en) | Tregitope constructs useful in the prevention and treatment of type 1 diabetes | |
| JP2023520989A5 (https=) | ||
| HK40045381A (en) | Regulatory t cell epitopes, compositions and uses thereof |